series-a
Stage
2020
Founded
2
Investors
About
Mbiomics develops scalable microbiome-based therapeutics for severe and chronic diseases using a proprietary analytics platform that combines AI and machine learning to design microbial consortia.
Explore mbiomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.